Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Padsevonil in drug-resistant focal-onset seizures
NCT03373383Phase 2Completed
- Sponsor
- UCB
- Start
- Feb 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 2 trial of padsevonil in focal onset seizure, sponsored by UCB. Started Feb 2018; status: completed.
02
Drugs
padsevonil
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT03373383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03373383.